{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:07:33Z","timestamp":1790518053010,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["17H06428"],"award-info":[{"award-number":["17H06428"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["18ek0109278h0002"],"award-info":[{"award-number":["18ek0109278h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"publisher","award":["2019A-1"],"award-info":[{"award-number":["2019A-1"]}],"id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"the Takeda Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Isolated hypogonadotropic hypogonadism (IHH), combined pituitary hormone deficiency (CPHD), and septo-optic dysplasia (SOD) constitute a disease spectrum whose etiology remains largely unknown. This study aimed to clarify whether mutations in <jats:italic>SMCHD1<\/jats:italic>, an epigenetic regulator gene, might underlie this disease spectrum. <jats:italic>SMCHD1<\/jats:italic> is a causative gene for Bosma arhinia microphthalmia syndrome characterized by arhinia, microphthalmia and IHH. We performed mutation screening of <jats:italic>SMCHD1<\/jats:italic> in patients with etiology-unknown IHH (n\u2009=\u200931) or CPHD (n\u2009=\u200943, 19 of whom also satisfied the SOD diagnostic criteria). Rare variants were subjected to in silico analyses and classified according to the American College of Medical Genetics and Genomics guidelines. Consequently, a rare likely pathogenic variant, p.Asp398Asn, was identified in one patient. The patient with p.Asp398Asn exhibited CPHD, optic nerve hypoplasia, and a thin retinal nerve fiber layer, and therefore satisfied the criteria of SOD. This patient showed a relatively low DNA methylation level of the 52 SMCHD1-target CpG sites at the <jats:italic>D4Z4<\/jats:italic> locus. Exome sequencing for the patient excluded additional variants in other IHH\/CPHD-causative genes. In vitro assays suggested functional impairment of the p.Asp398Asn variant. These results provide the first indication that <jats:italic>SMCHD1<\/jats:italic> mutations represent a rare genetic cause of the HH-related disease spectrum.<\/jats:p>","DOI":"10.1038\/s41598-020-67715-x","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T10:02:47Z","timestamp":1593770567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Rare variant of the epigenetic regulator SMCHD1 in a patient with pituitary hormone deficiency"],"prefix":"10.1038","volume":"10","author":[{"given":"Kenichi","family":"Kinjo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Muroya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erina","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ishiwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Nakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu-Suke","family":"Nozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikashi","family":"Obuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Miyado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Miyado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"67715_CR1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1210\/er.2016-1101","volume":"37","author":"Q Fang","year":"2016","unstructured":"Fang, Q. et al. Genetics of combined pituitary hormone deficiency: Roadmap into the genome era. Endocr. Rev. 37, 636\u2013675 (2016).","journal-title":"Endocr. Rev."},{"key":"67715_CR2","doi-asserted-by":"publisher","first-page":"R55","DOI":"10.1530\/EJE-17-0749","volume":"178","author":"L Maione","year":"2018","unstructured":"Maione, L. et al. Genetics in endocrinology: Genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: New challenges in the era of oligogenism and next-generation sequencing. Eur. J. Endocrinol. 178, R55\u2013R80 (2018).","journal-title":"Eur. J. Endocrinol."},{"key":"67715_CR3","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.gene.2013.10.043","volume":"534","author":"A Macchiaroli","year":"2014","unstructured":"Macchiaroli, A. et al. A novel heterozygous SOX2 mutation causing congenital bilateral anophthalmia, hypogonadotropic hypogonadism and growth hormone deficiency. Gene 534, 282\u2013285 (2014).","journal-title":"Gene"},{"key":"67715_CR4","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.3174\/ajnr.A3946","volume":"35","author":"R Manara","year":"2014","unstructured":"Manara, R. et al. Brain changes in Kallmann syndrome. Am. J. Neuroradiol. 35, 1700\u20131706 (2014).","journal-title":"Am. J. Neuroradiol."},{"key":"67715_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1297\/cpe.22.15","volume":"22","author":"T Tajima","year":"2013","unstructured":"Tajima, T., Ishizu, K. & Nakamura, A. Molecular and clinical findings in patients with LHX4 and OTX2 mutations. Clin. Pediatr. Endocrinol. 22, 15\u201323 (2013).","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"67715_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000152035","volume":"2","author":"V Tziaferi","year":"2008","unstructured":"Tziaferi, V., Kelberman, D. & Dattani, M. T. The role of SOX2 in hypogonadotropic hypogonadism. Sex. Dev. 2, 194\u2013199 (2008).","journal-title":"Sex. Dev."},{"key":"67715_CR7","doi-asserted-by":"publisher","first-page":"E694","DOI":"10.1210\/jc.2011-2938","volume":"97","author":"T Raivio","year":"2012","unstructured":"Raivio, T. et al. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. J. Clin. Endocrinol. Metab. 97, E694\u2013E699 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"67715_CR8","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1210\/er.2009-0008","volume":"30","author":"D Kelberman","year":"2009","unstructured":"Kelberman, D., Rizzoti, K., Lovell-Badge, R., Robinson, I. C. & Dattani, M. T. Genetic regulation of pituitary gland development in human and mouse. Endocr. Rev. 30, 790\u2013829 (2009).","journal-title":"Endocr. Rev."},{"key":"67715_CR9","first-page":"113","volume":"9","author":"AK Topalo\u011flu","year":"2017","unstructured":"Topalo\u011flu, A. K. Update on the genetics of idiopathic hypogonadotropic hypogonadism. J. Clin. Res. Pediatr. Endocrinol. 9, 113\u2013122 (2017).","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"67715_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.tig.2017.01.007","volume":"33","author":"N Jansz","year":"2017","unstructured":"Jansz, N., Chen, K., Murphy, J. M. & Blewitt, M. E. The epigenetic regulator SMCHD1 in development and disease. Trends Genet. 33, 233\u2013243 (2017).","journal-title":"Trends Genet."},{"key":"67715_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1756-8935-6-19","volume":"6","author":"AW Mould","year":"2013","unstructured":"Mould, A. W. et al. Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation. Epigenetics Chromatin 6, 19 (2013).","journal-title":"Epigenetics Chromatin"},{"key":"67715_CR12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ng.3776","volume":"49","author":"AOM Wilkie","year":"2017","unstructured":"Wilkie, A. O. M. Many faces of SMCHD1. Nat. Genet. 49, 176\u2013178 (2017).","journal-title":"Nat. Genet."},{"key":"67715_CR13","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1128\/MCB.00145-13","volume":"33","author":"AV Gendrel","year":"2013","unstructured":"Gendrel, A. V. et al. Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes. Mol. Cell. Biol. 33, 3150\u20133165 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"67715_CR14","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1128\/MCB.00432-15","volume":"35","author":"NJ Brideau","year":"2015","unstructured":"Brideau, N. J. et al. Independent mechanisms target SMCHD1 to trimethylated histone H3 lysine 9-modified chromatin and the inactive X chromosome. Mol. Cell. Biol. 35, 4053\u20134068 (2015).","journal-title":"Mol. Cell. Biol."},{"key":"67715_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nsmb.2532","volume":"20","author":"RS Nozawa","year":"2013","unstructured":"Nozawa, R. S. et al. Human inactive X chromosome is compacted through a PRC2-independent SMCHD1-HBiX1 pathway. Nat. Struct. Mol. Biol. 20, 566\u2013573 (2013).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"67715_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/ng.3743","volume":"49","author":"ND Shaw","year":"2017","unstructured":"Shaw, N. D. et al. SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome. Nat. Genet. 49, 238\u2013248 (2017).","journal-title":"Nat. Genet."},{"key":"67715_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/ng.3765","volume":"49","author":"CT Gordon","year":"2017","unstructured":"Gordon, C. T. et al. De novo mutations in SMCHD1 cause Bosma arhinia microphthalmia syndrome and abrogate nasal development. Nat. Genet. 49, 249\u2013255 (2017).","journal-title":"Nat. Genet."},{"key":"67715_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1136\/jmedgenet-2019-106168","volume":"56","author":"RJLF Lemmers","year":"2019","unstructured":"Lemmers, R. J. L. F. et al. SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain. J. Med. Genet. 56, 693\u2013700 (2019).","journal-title":"J. Med. Genet."},{"key":"67715_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1868-7083-6-23","volume":"6","author":"TI Jones","year":"2014","unstructured":"Jones, T. I. et al. Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing. Clin. Epigenetics 6, 23 (2014).","journal-title":"Clin. Epigenetics"},{"key":"67715_CR20","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ng.2454","volume":"44","author":"RJLF Lemmers","year":"2012","unstructured":"Lemmers, R. J. L. F. et al. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat. Genet. 44, 1370\u20131374 (2012).","journal-title":"Nat. Genet."},{"key":"67715_CR21","doi-asserted-by":"publisher","first-page":"e562","DOI":"10.1212\/WNL.0000000000005958","volume":"91","author":"K Mul","year":"2018","unstructured":"Mul, K. et al. FSHD type 2 and Bosma arhinia microphthalmia syndrome: Two faces of the same mutation. Neurology. 91, e562\u2013e570 (2018).","journal-title":"Neurology."},{"key":"67715_CR22","doi-asserted-by":"publisher","first-page":"9841","DOI":"10.1074\/jbc.RA118.003104","volume":"293","author":"AD Gurzau","year":"2018","unstructured":"Gurzau, A. D. et al. FSHD2- and BAMS-associated mutations confer opposing effects on SMCHD1 function. J. Biol. Chem. 293, 9841\u20139853 (2018).","journal-title":"J. Biol. Chem."},{"key":"67715_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ejhg.2009.125","volume":"18","author":"EA Webb","year":"2010","unstructured":"Webb, E. A. & Dattani, M. T. Septo-optic dysplasia. Eur. J. Hum. Genet. 18, 393\u2013397 (2010).","journal-title":"Eur. J. Hum. Genet."},{"key":"67715_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"67715_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1507\/endocrj.K10E-017","volume":"57","author":"T Kimura","year":"2010","unstructured":"Kimura, T. et al. Concordant and discordant adrenocorticotropin (ACTH) responses induced by growth hormone-releasing peptide-2 (GHRP-2), corticotropin-releasing hormone (CRH) and insulin-induced hypoglycemia in patients with hypothalamopituitary disorders: Evidence for direct ACTH releasing activity of GHRP-2. Endocr. J. 57, 639\u2013644 (2010).","journal-title":"Endocr. J."},{"key":"67715_CR26","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/cphy.c160039","volume":"7","author":"AM DeSimone","year":"2017","unstructured":"DeSimone, A. M., Pakula, A., Lek, A. & Emerson, C. P. Facioscapulohumeral muscular dystrophy. Compr. Physiol. 7, 1229\u20131279 (2017).","journal-title":"Compr. Physiol."},{"key":"67715_CR27","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/hmg\/ddz239","volume":"28","author":"C Strafella","year":"2019","unstructured":"Strafella, C. et al. The variability of SMCHD1 gene in FSHD patients: Evidence of new mutations. Hum. Mol. Genet. 28, 3912\u20133920 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"67715_CR28","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/hmg\/2.12.2037","volume":"2","author":"JC van Deutekom","year":"1993","unstructured":"van Deutekom, J. C. et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum. Mol. Genet. 2, 2037\u20132042 (1993).","journal-title":"Hum. Mol. Genet."},{"key":"67715_CR29","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/ejhg.2014.191","volume":"23","author":"M Larsen","year":"2015","unstructured":"Larsen, M. et al. Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1. Eur. J. Hum. Genet. 23, 808\u2013816 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"67715_CR30","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1530\/JME-14-0315","volume":"54","author":"AP Abreu","year":"2015","unstructured":"Abreu, A. P., Macedo, D. B., Brito, V. N., Kaiser, U. B. & Latronico, A. C. A new pathway in the control of the initiation of puberty: The MKRN3 gene. J. Mol. Endocrinol. 54, R131\u2013R139 (2015).","journal-title":"J. Mol. Endocrinol."},{"key":"67715_CR31","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/hmg\/3.9.1565","volume":"3","author":"N Okamoto","year":"1994","unstructured":"Okamoto, N. et al. Monoallelic expression of normal mRNA in the PIT1 mutation heterozygotes with normal phenotype and biallelic expression in the abnormal phenotype. Hum. Mol. Genet. 3, 1565\u20131568 (1994).","journal-title":"Hum. Mol. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67715-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67715-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67715-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:07:27Z","timestamp":1670332047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67715-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["67715"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-67715-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]},"assertion":[{"value":"26 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10985"}}